Category: Equity: Sectoral-Pharma and Healthcare |
Launch Date: 28-12-2015 |
Asset Class: Equity |
Benchmark: Nifty Pharma TRI |
TER: 2.21% As on (30-06-2024) |
Status: Open Ended Schemes |
Minimum Investment: 5000.0 |
Minimum Topup: 1000.0 |
Total Assets: 1,056.02 Cr As on 31-07-2024(Source:AMFI) |
Turn over: 22.57% | Exit Load: Exit load of 0.25% if redeemed within 30 days. |
Time it would have taken to make your money double (2x), quadruple (4x) and quintuple (5x)
The scheme seeks long term capital appreciation by investing atleast 80% of it's net assets in equity/equity related instruments of the companies in the pharma & healthcare sectors in India.
Standard Deviation | 15.09 |
Sharpe Ratio | 0.74 |
Alpha | 2.85 |
Beta | 0.9 |
Yield to Maturity | - |
Average Maturity | - |
Minimum investment in equity & equity related instruments of a particular sector/ particular theme - 80% of total assets.
Small Cap
18.02%
Others
4.61%
Large Cap
43.13%
Mid Cap
34.24%